BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12580506)

  • 1. Improvement in steroid screening for doping control with special emphasis on stanozolol.
    Huenerbein A; Sipoli Marques MA; Pereira Ados S; de Aquino Neto FR
    J Chromatogr A; 2003 Jan; 985(1-2):375-86. PubMed ID: 12580506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple Synthesis of 17-β-
    Casati S; Ottria R; Ciuffreda P
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32357494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical challenges in doping control: Comprehensive two-dimensional gas chromatography with time of flight mass spectrometry, a promising option.
    Silva AI; Pereira HM; Casilli A; Conceição FC; Aquino Neto FR
    J Chromatogr A; 2009 Apr; 1216(14):2913-22. PubMed ID: 19013575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market.
    Parr MK; Geyer H; Hoffmann B; Köhler K; Mareck U; Schänzer W
    Biomed Chromatogr; 2007 Feb; 21(2):164-8. PubMed ID: 17146762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control.
    Wang Z; Zhou X; Liu X; Dong Y; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():250-259. PubMed ID: 27842983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis.
    Göschl L; Gmeiner G; Gärtner P; Stadler G; Enev V; Thevis M; Schänzer W; Guddat S; Forsdahl G
    Drug Test Anal; 2021 Sep; 13(9):1668-1677. PubMed ID: 34089570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for anabolic steroids in hair from two bodybuilders.
    Kintz P; Cirimele V; Sachs H; Jeanneau T; Ludes B
    Forensic Sci Int; 1999 May; 101(3):209-16. PubMed ID: 10404632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.
    Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W
    Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional supplements cross-contaminated and faked with doping substances.
    Geyer H; Parr MK; Koehler K; Mareck U; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):892-902. PubMed ID: 18563865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of in vitro technologies to study the metabolism of the androgenic/anabolic steroid stanozolol in the equine.
    Scarth JP; Spencer HA; Hudson SC; Teale P; Gray BP; Hillyer LL
    Steroids; 2010 Jan; 75(1):57-69. PubMed ID: 19854209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on anabolic steroids. III. Detection and characterization of stanozolol urinary metabolites in humans by gas chromatography-mass spectrometry.
    Massé R; Ayotte C; Bi HG; Dugal R
    J Chromatogr; 1989 Dec; 497():17-37. PubMed ID: 2625454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control.
    Balcells G; Matabosch X; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-isobutyloxycarbonylation for improved detection of 3'-hydroxystanozolol and its 17-epimer in doping control.
    Choi MH; Chung BC
    Analyst; 2001 Mar; 126(3):306-9. PubMed ID: 11284331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing of the anabolic stanozolol in human hair by gas chromatography-negative ion chemical ionization mass spectrometry.
    Cirimele V; Kintz P; Ludes B
    J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):265-71. PubMed ID: 10821413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography-high-resolution mass spectrometry.
    Schänzer W; Delahaut P; Geyer H; Machnik M; Horning S
    J Chromatogr B Biomed Appl; 1996 Dec; 687(1):93-108. PubMed ID: 9001957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of anabolic steroids using GC/MS with selected ion monitoring.
    Chung BC; Choo HY; Kim TW; Eom KD; Kwon OS; Suh J; Yang J; Park J
    J Anal Toxicol; 1990; 14(2):91-5. PubMed ID: 2325383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of stanozolol in hair by negative ion chemical ionization mass spectrometry.
    Höld KM; Wilkins DG; Crouch DJ; Rollins DE; Maes RA
    J Anal Toxicol; 1996 Oct; 20(6):345-49. PubMed ID: 8889668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-dimensional gas chromatography with heart-cutting for isotope ratio mass spectrometry analysis of steroids in doping control.
    Brailsford AD; Gavrilović I; Ansell RJ; Cowan DA; Kicman AT
    Drug Test Anal; 2012 Dec; 4(12):962-9. PubMed ID: 22761127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.